Skip to main content
main-content
Erschienen in: Dysphagia 4/2022

20.07.2021 | Original Article

The Dosimetric Outcome of a Rotational Planning Target Volume in Patients With Oropharyngeal Cancers

verfasst von: Mona Arbab, Gregory Bartlett, Benjamin Dawson, Jeffrey Ge, Mark Langer

Erschienen in: Dysphagia | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

An isotropic expanded Planning Target Volume (PTV) neglects patient’s off-axis rotation. This study designs a rotational PTV that is used instead of the standard 3-mm Clinical Target Volume (CTV) expanded PTV in oropharyngeal cancers with the goal to reduce pharyngeal constrictor muscle (PCM) mean dose. 10 patients were retrospectively evaluated. For off-axis rotation, the image was rotated around the longitudinal axis (cervical spinal canal) ± 5 degrees. These new CTVs were combined to form the rotational PTV. The standard and rotational treatment plans were designed with the goal to keep the superior and middle PCM-CTV70 mean dose to less than 50 Gy. There were a 355 cGy reduction in the superior PCM mean dose (form 5332 to 4977 cGy) and a 506 cGy reduction in middle PCM mean dose (from 4185 to 3679 cGy). 60% of patients may have at least a 20% reduction in dysphagia probability based on a Normal Tissue Complication Probability (NTCP) formula. The superior and middle PCM mean dose were reduced to less than 50 Gy in 40 and 20% of cases. There was an association between superior PCM mean dose and overlap volume of PTV70 and superior PCM in both standard (r = 0.92, p = 0.001) and rotational (r = 0.84, p = 0.002) plans. This association was present for middle PCM and PTV70 (r = 0.52, p = 0.02 and r = 0.62, p = 0.006). Rotational PTV can lower the mean dose to superior and middle PCMs, ultimately leading to lower dysphagia rates.

Literatur
  1. Gupta T, Sinha S, Ghosh-Laskar S, et al. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial. Radiat Oncol. 2020;15(1):218. https://​doi.​org/​10.​1186/​s13014-020-01666-5.View ArticlePubMedPubMed Central
  2. Spiotto MT, Weichselbaum RR. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers. PLoS ONE. 2014;9(4): e94456. https://​doi.​org/​10.​1371/​journal.​pone.​0094456.View ArticlePubMedPubMed Central
  3. van Kranen S, Hamming-Vrieze O, Wolf A, Damen E, van Herk M, Sonke JJ. Head and neck margin reduction with adaptive radiation therapy: robustness of treatment plans against anatomy changes. Int J Radiat Oncol Biol Phys. 2016;96(3):653–60. https://​doi.​org/​10.​1016/​j.​ijrobp.​2016.​07.​011.View ArticlePubMed
  4. Platteaux N, Dirix P, Dejaeger E, Nuyts S. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia. 2010;25(2):139–52. https://​doi.​org/​10.​1007/​s00455-009-9247-7.View ArticlePubMed
  5. Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Annals Oncol Off J Eur Soc Med Oncol. 2004;15(3):383–8. https://​doi.​org/​10.​1093/​annonc/​mdh101.View Article
  6. Nguyen NP, Frank C, Moltz CC, et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol. 2006;80(3):302–6. https://​doi.​org/​10.​1016/​j.​radonc.​2006.​07.​031.View ArticlePubMed
  7. Xu B, Boero IJ, Hwang L, et al. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015;121(8):1303–11. https://​doi.​org/​10.​1002/​cncr.​29207.View ArticlePubMed
  8. Awan MJ, Mohamed AS, Lewin JS, et al. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014;50(8):746–52. https://​doi.​org/​10.​1016/​j.​oraloncology.​2014.​05.​003.View ArticlePubMedPubMed Central
  9. Patterson JM, Rapley T, Carding PN, Wilson JA, McColl E. Head and neck cancer and dysphagia; caring for carers. Psychooncology. 2013;22(8):1815–20. https://​doi.​org/​10.​1002/​pon.​3226.View ArticlePubMed
  10. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61(3):772–8. https://​doi.​org/​10.​1016/​j.​ijrobp.​2004.​06.​017.View ArticlePubMed
  11. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39. https://​doi.​org/​10.​1016/​j.​ijrobp.​2004.​05.​050.View ArticlePubMed
  12. Hunter KU, Lee OE, Lyden TH, et al. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head Neck. 2014;36(1):120–5. https://​doi.​org/​10.​1002/​hed.​23275.View ArticlePubMed
  13. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(22):3770–6. https://​doi.​org/​10.​1200/​jco.​2007.​14.​6647.View Article
  14. Christianen ME, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105(1):107–14. https://​doi.​org/​10.​1016/​j.​radonc.​2011.​08.​009.View ArticlePubMed
  15. Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;81(3):e93–9. https://​doi.​org/​10.​1016/​j.​ijrobp.​2010.​12.​067.View ArticlePubMedPubMed Central
  16. Christianen ME, van der Schaaf A, van der Laan HP, et al. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol. 2016;118(2):298–303. https://​doi.​org/​10.​1016/​j.​radonc.​2015.​11.​009.View ArticlePubMed
  17. Nutting C, Rooney K, Foran B, et al. Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer. J Clin Oncol. 2020;38(15):6508–608. https://​doi.​org/​10.​1200/​JCO.​2020.​38.​15_​suppl.​6508.View Article
  18. Hodapp N. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97–9. https://​doi.​org/​10.​1007/​s00066-011-0015-x.View ArticlePubMed
  19. Swartz EE, Floyd RT, Cendoma M. Cervical spine functional anatomy and the biomechanics of injury due to compressive loading. J Athl Train. 2005;40(3):155–61.PubMedPubMed Central
  20. Kuo C, Fanton M, Wu L, Camarillo D. Spinal constraint modulates head instantaneous center of rotation and dictates head angular motion. J Biomech. 2018;76:220–8.View Article
  21. Guckenberger M, Meyer J, Vordermark D, Baier K, Wilbert J, Flentje M. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys. 2006;65(3):934–42. https://​doi.​org/​10.​1016/​j.​ijrobp.​2006.​02.​019.View ArticlePubMed
  22. Van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):1121–35.View Article
  23. Arbab M, Ai H, Bartlett G, Dawson B, Langer M. The effect of designing a rotational planning target volume on sparing pharyngeal constrictor muscles in patients with oropharyngeal cancer. J Appl Clin Med Phys. 2020. https://​doi.​org/​10.​1002/​acm2.​13052.View ArticlePubMedPubMed Central
  24. Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101(3):394-402 doi: https://​doi.​org/​10.​1016/​j.​radonc.​2011.​05.​015
  25. Mazzola R, Ricchetti F, Fiorentino A, et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol. 2014;87(1044):20140543. https://​doi.​org/​10.​1259/​bjr.​20140543.View ArticlePubMedPubMed Central
  26. Rancati T, Schwarz M, Allen AM, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S64–9. https://​doi.​org/​10.​1016/​j.​ijrobp.​2009.​03.​079.View ArticlePubMedPubMed Central
  27. Petkar I, Rooney K, Roe JW, et al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016;16(1):770. https://​doi.​org/​10.​1186/​s12885-016-2813-0.View ArticlePubMedPubMed Central
  28. van der Laan HP, Gawryszuk A, Christianen ME, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction. Radiother Oncol. 2013;107(3):282–7. https://​doi.​org/​10.​1016/​j.​radonc.​2013.​05.​004.View ArticlePubMed
  29. Djordjevic M, Sjöholm E, Tullgren O, Sorcini B. Assessment of residual setup errors for anatomical sub-structures in image-guided head-and-neck cancer radiotherapy. Acta Oncol. 2014;53(5):646–53. https://​doi.​org/​10.​3109/​0284186x.​2013.​862593.View ArticlePubMed
Metadaten
Titel
The Dosimetric Outcome of a Rotational Planning Target Volume in Patients With Oropharyngeal Cancers
verfasst von
Mona Arbab
Gregory Bartlett
Benjamin Dawson
Jeffrey Ge
Mark Langer
Publikationsdatum
20.07.2021
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 4/2022
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-021-10341-0

Weitere Artikel der Ausgabe 4/2022

Dysphagia 4/2022 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.